S-4853-119
Read twice and referred to the Committee on Foreign Relations.
Sponsored by John Hoeven (R-ND)
What it does
This bill would amend the National Agricultural Research, Extension, and Teaching Policy Act of 1977 to modify the U.S.-Israel Binational Agricultural Research and Development (BARD) Fund. It would add a new "mid-stage research" purpose to the fund's existing mission and create a new accelerator program within the BARD Fund to fast-track cooperative agricultural research projects between U.S. and Israeli scientists. The bill would authorize $8 million per year in appropriations for fiscal years 2027 through 2031, for a total of $40 million over five years.
Who benefits
U.S. and Israeli agricultural scientists and researchers who would gain access to new funding and accelerator resources. U.S. universities and research institutions that participate in BARD-funded projects. American agricultural businesses and startups that could commercialize research outputs, including patents and breeding rights licenses. Farmers who may benefit from new agricultural practices developed through the program. The broader U.S. agricultural sector, which could gain competitive advantages from jointly developed technologies.
Who is hurt
U.S. taxpayers who fund the $40 million authorization. Other agricultural research programs that compete for limited federal discretionary funding and may face indirect budget pressure. Non-Israeli foreign research partners who do not benefit from this bilateral arrangement. Domestic-only research institutions that do not participate in international collaborations and would not be eligible for these funds.
Supporters argue
Supporters argue that the BARD Fund has a demonstrated track record of efficiency, with Congress's own findings citing a $16 return for every $1 spent across more than 1,300 projects and $315 million in total investment since 1977. They contend that adding a mid-stage accelerator fills a critical gap between early-stage research and commercial application, helping promising agricultural innovations reach farmers and markets faster rather than stalling in development.
Opponents argue
Opponents argue that directing $40 million in federal agricultural research funds exclusively to a bilateral program with one country creates an inequitable structure that excludes other valuable international research partners. They contend that the bill's claimed $16-per-dollar return figure is drawn from the bill's own findings rather than independent evaluation, and that the accelerator program's scope and accountability mechanisms are loosely defined, leaving significant discretion to the BARD Fund with limited congressional oversight.